Oxana V Crysler ( Makarova-Rusher) MD, MHS
Assistant Professor of Internal Medicine
Rogel Cancer Center
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
[email protected]

Available to mentor
Oxana V Crysler ( Makarova-Rusher) MD, MHS
Clinical Assistant Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report.
      Chandana SR, Frisch A, Mendoza S, Sinniah RS, Crysler O, Banga R, Perkins DE. J Gastrointest Oncol, 2024 Feb 29; 15 (1): 478 - 484. DOI:10.21037/jgo-23-139
      PMID: 38482230
    • Journal Article
      Early Gastric Signet Ring Cell Adenocarcinoma
      Crysler O. 2024 Feb 11;
    • Presentation
      Systemic Treatment for Hepatocellular Carcinoma
      Crysler O. 2023 Nov 30;
    • Proceeding / Abstract / Poster
      Data from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2023 Jul 5; DOI:10.1158/1078-0432.c.6651163
    • Journal Article
      Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. Clin Cancer Res, 2023 Jul 5; 29 (13): 2394 - 2400. DOI:10.1158/1078-0432.CCR-23-0036
      PMID: 37115501
    • Proceeding / Abstract / Poster
      Phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy following first-line platinum-based chemotherapy in patients with advanced biliary tract cancer (BTC): BilT-02.
      Sahai V, Griffith KA, Goff LW, Crysler OV, Enzler T, Zalupski M. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): 4113 - 4113. DOI:10.1200/jco.2023.41.16_suppl.4113
    • Journal Article
      Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository.
      Pasternak AL, Seda R, Lipa J, McDevitt RL, Crysler OV, Swiecicki PL, Schneider BJ, Vanderwerff B, Henry NL, Krauss JC, Sahai V, Hertz DL. Clin Pharmacol Ther, 2023 Aug; 114 (2): 356 - 361. DOI:10.1002/cpt.2936
      PMID: 37163252
    • Proceeding / Abstract / Poster
      Data from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2023 May 17; DOI:10.1158/1078-0432.c.6651163.v1